Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Quelling of Excitotoxicity in Acute Stroke With Ketamine
Lower Merion Neurology Research Foundation
Ketamine Treatment for PTSD and MDD in TBI
Minneapolis Veterans Affairs Medical Center
Ketamine in Severe Traumatic Brain Injury
University of Texas Southwestern Medical Center
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
Psilocybin to Treat Depression in Spinal Cord Injury
James J. Peters Veterans Affairs Medical Center
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
Region Skane
Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
Zeliha Alicikus
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Alan Davis
Ketamine and Propofol NeuroImaging
Keith M Vogt
A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression
Daniel Lindqvist
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
University of Pennsylvania
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Mohsen Saidinejad
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
University of Colorado, Denver
MDMA-assisted Therapy for Fibromyalgia
Spaulding Rehabilitation Hospital
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Gustavo Vazquez
MDMA-Assisted Massed Exposure Therapy for PTSD
Emory University
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Massachusetts General Hospital
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Sunstone Medical
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
University Hospital, Basel, Switzerland
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Salma Health, Inc.
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
University Hospital, Basel, Switzerland
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
University of Virginia
Prospective IR-led Sedation Feasibility
CAMC Health System
Ketamine for Veterans With Parkinson's Disease
VA Office of Research and Development
Psilocybin for Prolonged Grief Disorder
University of Virginia
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Francisco A Moreno
MDMA-Assisted Therapy for Mental Healthcare Providers
Rachel Yehuda
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
Suzanne "Sue" Sisley MD
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Johns Hopkins University
Ketamine for Opioid Use Disorder
University of Maryland, Baltimore
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
Unity Health Toronto
LSD Treatment for Persons With Alcohol Use Disorder
Felix Mueller
Pilot Study of RR-HNK in OCD
Carolyn Rodriguez
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
The Ketamine Research Foundation
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Janssen Research & Development, LLC
RCT of Psilocybin-assisted CBT for Depression
University of California, Los Angeles
Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Bruyère Health Research Institute.
Psilocybin on Brain Mechanisms of Motivation in OUD
Anna Rose Childress, Ph.D.
Psilocybin for Opioid Use Disorder (OUD)
NYU Langone Health
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
Definium Therapeutics US, Inc.
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
VA Office of Research and Development
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
ACADIA Pharmaceuticals Inc.
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Texas Tech University Health Sciences Center
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Medical University of Vienna
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
University of California, Berkeley
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
University of British Columbia
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.